Primary cutaneous follicle centre lymphoma pathophysiology: Difference between revisions
Line 28: | Line 28: | ||
{|style="margin: 0 auto;" | {|style="margin: 0 auto;" | ||
| [[File:Primary cutaneous follicle centre lymphoma image 06.jpg| | | [[File:Primary cutaneous follicle centre lymphoma image 06.jpg|150px|thumb|upright|The epidermis is preserved, with diffuse and nodular infiltrates of lymphoid cells.<ref name=biomedcentral>Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature. BioMed Central. https://ro-journal.biomedcentral.com/articles/10.1186/1748-717X-8-147. Accessed on March 02, 2016</ref>]] | ||
| [[File:Primary cutaneous follicle centre lymphoma image 07.jpg|200px|thumb|upright|The infiltrate is composed of atypical, medium-sized and focally large lymphatic cells.<ref name=biomedcentral>Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature. BioMed Central. https://ro-journal.biomedcentral.com/articles/10.1186/1748-717X-8-147. Accessed on March 02, 2016</ref>]] | | [[File:Primary cutaneous follicle centre lymphoma image 07.jpg|200px|thumb|upright|The infiltrate is composed of atypical, medium-sized and focally large lymphatic cells.<ref name=biomedcentral>Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature. BioMed Central. https://ro-journal.biomedcentral.com/articles/10.1186/1748-717X-8-147. Accessed on March 02, 2016</ref>]] | ||
| [[File:Primary cutaneous follicle centre lymphoma image 08.jpg|250px|thumb|upright|Immunohistochemical staining for CD20 demonstrates diffusely positive reaction in tumour cells (A: IHC, CD20), coexpressing BCL6 (B: IHC, BCL6).<ref name=biomedcentral>Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature. BioMed Central. https://ro-journal.biomedcentral.com/articles/10.1186/1748-717X-8-147. Accessed on March 02, 2016</ref>]] | | [[File:Primary cutaneous follicle centre lymphoma image 08.jpg|250px|thumb|upright|Immunohistochemical staining for CD20 demonstrates diffusely positive reaction in tumour cells (A: IHC, CD20), coexpressing BCL6 (B: IHC, BCL6).<ref name=biomedcentral>Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature. BioMed Central. https://ro-journal.biomedcentral.com/articles/10.1186/1748-717X-8-147. Accessed on March 02, 2016</ref>]] |
Revision as of 17:49, 2 March 2016
Primary cutaneous follicle centre lymphoma Microchapters |
Differentiating Primary cutaneous follicle centre lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary cutaneous follicle centre lymphoma pathophysiology On the Web |
American Roentgen Ray Society Images of Primary cutaneous follicle centre lymphoma pathophysiology |
FDA on Primary cutaneous follicle centre lymphoma pathophysiology |
CDC on Primary cutaneous follicle centre lymphoma pathophysiology |
Primary cutaneous follicle centre lymphoma pathophysiology in the news |
Blogs on Primary cutaneous follicle centre lymphoma pathophysiology |
Directions to Hospitals Treating Splenic marginal zone lymphoma |
Risk calculators and risk factors for Primary cutaneous follicle centre lymphoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Primary cutaneous follicle center lymphoma is a tumor of neoplastic follicle centre cells, including centrocytes and variable numbers of centroblasts, with a follicular and diffuse growth pattern that generally presents on the head or trunk. This is the most common type of primary cutaneous B-cell lymphoma.[1] Primary cutaneous follicle center lymphoma (PCFCL) may be associated with borrelia burgdorferi, hepatitis C, and human herpesvirus 8. On gross pathology,solitary or grouped erythematous papules, plaques and tumor lesions, mostly non-ulcerated are characteristic findings of primary cutaneous follicle center lymphoma. On microscopic histopathological analysis, centroblasts (large noncleaved cells), centrocytes (small and large cleaved cells), and reactive T cells are characteristic findings of primary cutaneous follicle center lymphoma.[2]
Pathophysiology
Primary cutaneous follicle center lymphoma (PCFCL) is characterized by a proliferation of follicle center cells (centrocytes and centroblasts) with a follicular, follicular and diffuse, or diffuse growth pattern.[3]
Genetics
Genes involved in the pathogenesis of primary cutaneous follicle centre lymphoma include:[1]
- Amplification of C-REL gene
- BCL-2 rearrangements
Association
Primary cutaneous follicle center lymphoma (PCFCL) may be associated with:[2]
Gross Pathology
On gross pathology, solitary or grouped erythematous papules, plaques and tumor lesions, mostly non-ulcerated are characteristic findings of primary cutaneous follicle center lymphoma.[2]
Microscopic Pathology
On microscopic histopathological analysis, centroblasts (large noncleaved cells), centrocytes (small and large cleaved cells), and reactive T cells are characteristic findings of primary cutaneous follicle center lymphoma.[2]
References
- ↑ 1.0 1.1 Primary cutaneous follicle centre lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf5ae3e27c3994bd549b/. Accessed on March 02, 2016
- ↑ 2.0 2.1 2.2 2.3 Ceovic R, Jovanovic I, Kostovic K, Rados J, Dotlic S, Radman I; et al. (2013). "Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature". Radiat Oncol. 8: 147. doi:10.1186/1748-717X-8-147. PMC 3702489. PMID 23786884.
- ↑ Transformation of a Cutaneous Follicle Center Lymphoma to a Diffuse Large B-Cell Lymphoma—An Unusual Presentation. Hindawi. http://www.hindawi.com/journals/crim/2010/296523/. Accessed on March 02, 2016
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Primary cutaneous follicle centre lymphoma. BioMed Central. https://biomarkerres.biomedcentral.com/articles/10.1186/2050-7771-2-7. Accessed on March 01, 2016